Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 562.3 | nM | PubChem BioAssay data set |
NPT536 | Uncleic Acid | microRNA 21 | Homo sapiens | Potency | = | 2930.9 | nM | PubChem BioAssay data set |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 10000 | nM | PubChem BioAssay data set |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Potency | = | 398107.2 | nM | PubChem BioAssay data set |
NPT211 | Individual Protein | Hypoxia-inducible factor 1 alpha | Homo sapiens | Potency | = | 2511.9 | nM | PubChem BioAssay data set |
NPT56 | Individual Protein | Beta-lactamase AmpC | Escherichia coli K-12 | Potency | = | 89125.1 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | IC50 | = | 9792 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 259.3 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 23109.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 11.2 | nM | PubChem BioAssay data set | ||
NPT71 | Cell Line | HEK293 | Homo sapiens | Potency | 730.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 1299.5 | nM | PubChem BioAssay data set | ||
NPT445 | Individual Protein | Peripheral myelin protein 22 | Rattus norvegicus | Potency | 9992.4 | nM | PubChem BioAssay data set | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 326.4 | nM | PubChem BioAssay data set | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 6513.1 | nM | PubChem BioAssay data set | |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 1000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 4109.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 366.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10593.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21136 | nM | PubChem BioAssay data set | ||
NPT920 | Individual Protein | Alpha-synuclein | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 8485.2 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 5353.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 1883.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1584.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 119.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 841.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 943.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 0.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2683.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1059.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1995.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1678.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 5308 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 23710.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1333.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 4730.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2131.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 7497.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1496 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 12589.3 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC109188 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.7841 | Intermediate Similarity | NPC319753 |
0.7273 | Intermediate Similarity | NPC329077 |
0.7 | Intermediate Similarity | NPC325902 |
0.6735 | Remote Similarity | NPC171116 |
0.6667 | Remote Similarity | NPC325723 |
0.6598 | Remote Similarity | NPC89051 |
0.6598 | Remote Similarity | NPC43246 |
0.6531 | Remote Similarity | NPC163352 |
0.6531 | Remote Similarity | NPC210456 |
0.64 | Remote Similarity | NPC315063 |
0.6311 | Remote Similarity | NPC36985 |
0.6311 | Remote Similarity | NPC17892 |
0.6289 | Remote Similarity | NPC106780 |
0.625 | Remote Similarity | NPC283698 |
0.625 | Remote Similarity | NPC73765 |
0.6224 | Remote Similarity | NPC71339 |
0.6224 | Remote Similarity | NPC112842 |
0.6196 | Remote Similarity | NPC315806 |
0.6095 | Remote Similarity | NPC317639 |
0.6019 | Remote Similarity | NPC324390 |
0.6 | Remote Similarity | NPC324516 |
0.6 | Remote Similarity | NPC318166 |
0.5962 | Remote Similarity | NPC322594 |
0.5962 | Remote Similarity | NPC327344 |
0.5962 | Remote Similarity | NPC320249 |
0.5877 | Remote Similarity | NPC155087 |
0.5877 | Remote Similarity | NPC149843 |
0.5841 | Remote Similarity | NPC329277 |
0.5726 | Remote Similarity | NPC325750 |
0.5684 | Remote Similarity | NPC126186 |
0.5678 | Remote Similarity | NPC478024 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC109188 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD1331 | Approved |
0.7766 | Intermediate Similarity | NPD1686 | Approved |
0.6598 | Remote Similarity | NPD9580 | Clinical (unspecified phase) |
0.6598 | Remote Similarity | NPD9581 | Clinical (unspecified phase) |
0.6574 | Remote Similarity | NPD1385 | Discontinued |
0.6458 | Remote Similarity | NPD9559 | Phase 1 |
0.64 | Remote Similarity | NPD755 | Phase 3 |
0.6389 | Remote Similarity | NPD4743 | Phase 2 |
0.625 | Remote Similarity | NPD9639 | Clinical (unspecified phase) |
0.625 | Remote Similarity | NPD9558 | Phase 3 |
0.625 | Remote Similarity | NPD9556 | Approved |
0.6224 | Remote Similarity | NPD280 | Approved |
0.62 | Remote Similarity | NPD1760 | Approved |
0.6196 | Remote Similarity | NPD9653 | Clinical (unspecified phase) |
0.6186 | Remote Similarity | NPD9560 | Approved |
0.6186 | Remote Similarity | NPD9561 | Approved |
0.6176 | Remote Similarity | NPD9565 | Discontinued |
0.6162 | Remote Similarity | NPD9557 | Clinical (unspecified phase) |
0.6122 | Remote Similarity | NPD9546 | Phase 2 |
0.6117 | Remote Similarity | NPD251 | Approved |
0.61 | Remote Similarity | NPD240 | Phase 3 |
0.6078 | Remote Similarity | NPD841 | Approved |
0.6064 | Remote Similarity | NPD9407 | Approved |
0.6061 | Remote Similarity | NPD9533 | Phase 2 |
0.604 | Remote Similarity | NPD241 | Discontinued |
0.602 | Remote Similarity | NPD2691 | Clinical (unspecified phase) |
0.5979 | Remote Similarity | NPD9429 | Discontinued |
0.5941 | Remote Similarity | NPD9562 | Discovery |
0.5941 | Remote Similarity | NPD170 | Approved |
0.59 | Remote Similarity | NPD239 | Phase 2 |
0.59 | Remote Similarity | NPD238 | Clinical (unspecified phase) |
0.5893 | Remote Similarity | NPD3128 | Phase 3 |
0.5841 | Remote Similarity | NPD3129 | Phase 3 |
0.5833 | Remote Similarity | NPD502 | Approved |
0.58 | Remote Similarity | NPD9529 | Phase 1 |
0.58 | Remote Similarity | NPD882 | Phase 2 |
0.58 | Remote Similarity | NPD883 | Phase 2 |
0.578 | Remote Similarity | NPD3121 | Phase 2 |
0.578 | Remote Similarity | NPD5789 | Clinical (unspecified phase) |
0.5745 | Remote Similarity | NPD9405 | Approved |
0.5741 | Remote Similarity | NPD762 | Discontinued |
0.5727 | Remote Similarity | NPD223 | Clinical (unspecified phase) |
0.5714 | Remote Similarity | NPD1061 | Clinical (unspecified phase) |
0.5702 | Remote Similarity | NPD7756 | Clinical (unspecified phase) |
0.5701 | Remote Similarity | NPD1706 | Clinical (unspecified phase) |
0.566 | Remote Similarity | NPD6943 | Clinical (unspecified phase) |
0.5641 | Remote Similarity | NPD1804 | Phase 2 |
0.5641 | Remote Similarity | NPD1805 | Phase 2 |
0.5625 | Remote Similarity | NPD7651 | Approved |
PubChem CID   | 16574 |
ChEMBL   | CHEMBL515914 |
ZINC   |
Molecular Weight:   | 371.10 |
ALogP:   | -0.723 |
MLogP:   | 1.68 |
XLogP:   | -0.251 |
# Rotatable Bonds:   | 12 |
Polar Surface Area:   | 153.39 |
# H-Bond Aceptor:   | 12 |
# H-Bond Donor:   | 1 |
# Rings:   | 2 |
# Heavy Atoms:   | 26 |